NO20020718L - Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS - Google Patents

Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS

Info

Publication number
NO20020718L
NO20020718L NO20020718A NO20020718A NO20020718L NO 20020718 L NO20020718 L NO 20020718L NO 20020718 A NO20020718 A NO 20020718A NO 20020718 A NO20020718 A NO 20020718A NO 20020718 L NO20020718 L NO 20020718L
Authority
NO
Norway
Prior art keywords
ras
methods
protein kinase
compositions useful
modulating angiogenesis
Prior art date
Application number
NO20020718A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020718D0 (no
Inventor
David A Cheresh
Brian Eliceiri
John Hood
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO20020718D0 publication Critical patent/NO20020718D0/no
Publication of NO20020718L publication Critical patent/NO20020718L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20020718A 1999-08-13 2002-02-12 Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS NO20020718L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14892499P 1999-08-13 1999-08-13
US21595100P 2000-07-05 2000-07-05
PCT/US2000/021842 WO2001012210A1 (en) 1999-08-13 2000-08-11 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras

Publications (2)

Publication Number Publication Date
NO20020718D0 NO20020718D0 (no) 2002-02-12
NO20020718L true NO20020718L (no) 2002-04-10

Family

ID=26846311

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020718A NO20020718L (no) 1999-08-13 2002-02-12 Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS

Country Status (17)

Country Link
US (1) US20060040853A1 (hu)
EP (1) EP1210099A4 (hu)
JP (1) JP2003507337A (hu)
KR (2) KR100805098B1 (hu)
CN (1) CN1208087C (hu)
AU (1) AU781877B2 (hu)
BR (1) BR0013228A (hu)
CA (1) CA2380966A1 (hu)
CZ (1) CZ2002449A3 (hu)
HK (1) HK1050856A1 (hu)
HU (1) HUP0300923A3 (hu)
MX (1) MXPA02001553A (hu)
NO (1) NO20020718L (hu)
PL (1) PL364928A1 (hu)
RU (1) RU2257911C2 (hu)
SK (1) SK2142002A3 (hu)
WO (1) WO2001012210A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002026246A2 (en) * 2000-09-29 2002-04-04 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Pharmaceutical compositions comprising polynucleotides encoding a raf protein
EP3023422A1 (en) * 2007-03-12 2016-05-25 YM BioSciences Australia Pty Ltd Phenyl amino pyrimidine compounds and uses thereof
KR20100102152A (ko) 2008-01-14 2010-09-20 제넨테크, 인크. Ｅｇｆｌ8 길항제를 사용하여 혈관신생을 억제하는 방법
EP2329854A3 (de) * 2009-12-04 2014-02-19 Biotronik VI Patent AG Implantatbeschichtung mit Nukleinsäuren
CN102766601B (zh) * 2011-11-17 2015-12-16 中山大学肿瘤防治中心 含有可诱导型癌基因的细胞系及其建立方法、应用
CN106686981B (zh) 2014-06-03 2020-03-10 赫雷拉 A·索利斯 角膜血管生成和角膜扩张疾病的动物模型，其制备方法，以及其使用方法
RU2728870C2 (ru) * 2017-10-12 2020-07-31 Федеральное государственное бюджетное учреждение "Российский научный центр рентгенорадиологии" Министерства здравоохранения российской федерации (ФГБУ "РНЦРР" Минздрава России) Полипептиды для лечения онкологических заболеваний
WO2021211784A2 (en) * 2020-04-15 2021-10-21 Cohbar, Inc. Method of treating coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5156841A (en) * 1988-08-26 1992-10-20 United States Of America Anti-tumor vaccine
US5618670A (en) * 1988-08-26 1997-04-08 The United States Of America As Represented By The Department Of Health & Human Services Detection method for c-raf-1 genes
US5656612A (en) 1994-05-31 1997-08-12 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of raf gene expression
US5597719A (en) * 1994-07-14 1997-01-28 Onyx Pharmaceuticals, Inc. Interaction of RAF-1 and 14-3-3 proteins
US5795910A (en) * 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
US6300081B1 (en) * 1996-11-15 2001-10-09 Cornell Research Foundation, Inc. Activated ras interaction assay
US6376471B1 (en) * 1997-10-10 2002-04-23 Johns Hopkins University Gene delivery compositions and methods

Also Published As

Publication number Publication date
HUP0300923A3 (en) 2005-12-28
CN1208087C (zh) 2005-06-29
KR100805098B1 (ko) 2008-02-20
SK2142002A3 (en) 2002-07-02
CA2380966A1 (en) 2001-02-22
KR100759241B1 (ko) 2007-09-18
KR20070067210A (ko) 2007-06-27
US20060040853A1 (en) 2006-02-23
JP2003507337A (ja) 2003-02-25
BR0013228A (pt) 2003-06-17
AU6763300A (en) 2001-03-13
RU2257911C2 (ru) 2005-08-10
MXPA02001553A (es) 2003-05-23
NO20020718D0 (no) 2002-02-12
WO2001012210A1 (en) 2001-02-22
PL364928A1 (en) 2004-12-27
HUP0300923A2 (hu) 2003-07-28
CZ2002449A3 (cs) 2002-08-14
CN1378457A (zh) 2002-11-06
AU781877B2 (en) 2005-06-16
KR20020032553A (ko) 2002-05-03
EP1210099A1 (en) 2002-06-05
EP1210099A4 (en) 2006-01-18
WO2001012210A9 (en) 2002-09-12
HK1050856A1 (en) 2003-07-11

Similar Documents

Publication Publication Date Title
NO20031500D0 (no) Brodekkepaneler, fremgangsmåte for fremstilling av samme og broer omfattende samme
NO992336D0 (no) Raf-kinase-inhibitorer
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
NO995660L (no) FremgangsmÕte ved kommunikasjon og anordning for samme
NO2008012I1 (no) Dabigatran-etexilate og salter derav-spesielt dabigatran-etexilate-mesylate
DK0985697T3 (da) Oxiranderivater og fremgangsmåde til fremstilling deraf
NO20012774L (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
IS6724A (is) Aðferð til framleiðslu á N-arýl-anþranilískum sýrum og afleiðum þeirra
NO20021736L (no) Nytt preparat og fremgangsmåte for stabilisering av det
NO20005017D0 (no) Metoder og viskøse sammensetninger for behandling av brønner
NO20013803D0 (no) Polymert adsorpsjonsmiddel og fremgangsmåte til fremstilling av samme
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20030800D0 (no) Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme
NO20021989L (no) Törkingsanlegg og metode for törking av ved
NO20006296D0 (no) Fremgangsmåte til fremstilling av filtpapp og filtpapp
NO20020718L (no) Fremgangsmater og sammensetninger nyttige for modulering av angiogenese ved a bruke protein kinase RAF og RAS
NO993437D0 (no) Koplingsanordning og fremgangsmåte til bruk av koplingsanordningen
NO20003555L (no) Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
NO20004349D0 (no) Metoder og anordninger for modulering av immunresponsen
NO993034D0 (no) Bjelke og fremgangsmÕte ved fremstilling av samme
DE60028202D1 (de) Behälter zum einschluss von kernbrennelementen
NO943702D0 (no) Fremgangsmåter ved anvendelse av surgjörende fluider, brönner og sammensetninger benyttet deri
NO20024105L (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application